|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | Apr 02 '25 | Sale | 1.07 | 1,887 | 2,019 | 467,226 | Apr 03 04:21 PM |
| VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | Mar 28 '25 | Option Exercise | 0.00 | 4,531 | 0 | 469,113 | Apr 01 04:35 PM |
| VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | Dec 27 '24 | Sale | 2.36 | 21,119 | 49,841 | 464,582 | Dec 30 05:33 PM |
| VTYX | Nuss John | Officer | Dec 27 '24 | Proposed Sale | 2.36 | 21,119 | 49,842 | Dec 27 04:46 PM | |
| VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | Dec 17 '24 | Option Exercise | 0.00 | 34,930 | 0 | 498,862 | Dec 19 06:50 PM |
| VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | Dec 19 '24 | Sale | 2.26 | 13,161 | 29,682 | 485,701 | Dec 19 06:50 PM |
| VTYX | Nuss John | Officer | Dec 19 '24 | Proposed Sale | 2.26 | 13,161 | 29,682 | Dec 19 06:48 PM | |
| VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | Dec 10 '24 | Option Exercise | 0.20 | 198,934 | 39,787 | 463,932 | Dec 11 05:21 PM |
| VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | Apr 02 '24 | Sale | 5.40 | 1,651 | 8,921 | 264,998 | Apr 03 07:33 PM |
| VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | Mar 28 '24 | Option Exercise | 0.00 | 4,531 | 0 | 266,649 | Mar 29 06:07 PM |
| VTYX | Nuss John | Chief Scientific Officer | Dec 20 '23 | Sale | 2.12 | 17,628 | 37,334 | 262,118 | Dec 21 08:14 PM |
| VTYX | Nuss John | Chief Scientific Officer | Dec 17 '23 | Option Exercise | 0.00 | 34,931 | 0 | 279,746 | Dec 19 05:27 PM |
| VTYX | Nuss John | Chief Scientific Officer | Oct 03 '23 | Option Exercise | 3.35 | 10,000 | 33,542 | 254,815 | Oct 04 07:26 PM |
| VTYX | Nuss John | Chief Scientific Officer | Oct 03 '23 | Sale | 29.99 | 10,000 | 299,933 | 244,815 | Oct 04 07:26 PM |
| VTYX | Nuss John | Chief Scientific Officer | Sep 05 '23 | Option Exercise | 0.20 | 10,000 | 2,000 | 254,815 | Sep 07 04:21 PM |
| VTYX | Nuss John | Chief Scientific Officer | Sep 05 '23 | Sale | 32.60 | 10,000 | 325,960 | 244,815 | Sep 07 04:21 PM |
| VTYX | Nuss John | Chief Scientific Officer | Aug 03 '23 | Option Exercise | 0.20 | 10,000 | 2,000 | 254,815 | Aug 04 06:08 PM |
| VTYX | Nuss John | Chief Scientific Officer | Aug 03 '23 | Sale | 35.60 | 10,000 | 355,986 | 244,815 | Aug 04 06:08 PM |
| VTYX | Nuss John | Chief Scientific Officer | Jul 03 '23 | Option Exercise | 0.20 | 20,000 | 4,000 | 264,815 | Jul 05 08:20 PM |
| VTYX | Nuss John | Chief Scientific Officer | Jul 03 '23 | Sale | 39.58 | 20,000 | 791,637 | 244,815 | Jul 05 08:20 PM |
| VTYX | Nuss John | Chief Scientific Officer | Jun 05 '23 | Option Exercise | 0.20 | 10,000 | 2,000 | 254,815 | Jun 07 06:59 PM |
| VTYX | Nuss John | Chief Scientific Officer | Jun 05 '23 | Sale | 34.35 | 10,000 | 343,467 | 244,815 | Jun 07 06:59 PM |
| VTYX | Nuss John | Chief Scientific Officer | May 03 '23 | Option Exercise | 0.20 | 10,000 | 2,000 | 254,815 | May 04 04:10 PM |
| VTYX | Nuss John | Chief Scientific Officer | May 03 '23 | Sale | 38.64 | 10,000 | 386,371 | 244,815 | May 04 04:10 PM |
| VTYX | Nuss John | Chief Scientific Officer | Apr 03 '23 | Option Exercise | 0.20 | 30,000 | 6,000 | 274,815 | Apr 05 07:13 PM |
| VTYX | Nuss John | Chief Scientific Officer | Apr 03 '23 | Sale | 32.87 | 30,000 | 986,233 | 244,815 | Apr 05 07:13 PM |
| VTYX | Nuss John | Chief Scientific Officer | Dec 22 '22 | Sale | 31.61 | 13,812 | 436,654 | 244,815 | Dec 23 06:33 PM |
| VTYX | Nuss John | Chief Scientific Officer | Dec 17 '22 | Option Exercise | 0.00 | 34,931 | 0 | 258,627 | Dec 20 08:02 PM |
| VTYX | Nuss John | Chief Scientific Officer | Dec 13 '22 | Sale | 34.32 | 35,000 | 1,201,078 | 223,696 | Dec 15 05:00 PM |
| VTYX | Nuss John | Chief Scientific Officer | Dec 05 '22 | Sale | 28.23 | 50,000 | 1,411,311 | 258,696 | Dec 06 05:00 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite